valine has been researched along with Dyskinesia, Medication-Induced in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, H; Ogawa, Y; Rathbone, J; Shinohara, K; Soares-Weiser, K | 1 |
| Estevez-Fraga, C; López-Sendón Moreno, JL; Zeun, P | 1 |
| Müller, T | 1 |
| Kim, JI; Kim, YH; Kong, BG; Lee, CH; Lee, JG; Lee, SJ; Park, SW | 1 |
| de Lau, LM; Heutink, P; Marinus, J; van Hilten, JJ; Verbaan, D | 1 |
| Hou, G; Sha, W; Yao, H; Zhang, X; Zhang, Z | 1 |
| Bai, YM; Chen, JY; Lai, IC; Liao, DL; Lin, CC; Lin, CY; Liou, YJ; Wang, YC; Yu, SC | 1 |
| Jun, TY; Kim, JJ; Kim, TS; Lee, C; Lee, CU; Lee, SJ; Pae, CU; Paik, IH; Patkar, AA | 1 |
| Su, JM; Tan, YL; Zhou, DF | 1 |
| Blanchet, PJ; Chase, TN; Konitsiotis, S; Whittemore, ER; Woodward, RM; Zhou, ZL | 1 |
2 review(s) available for valine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Dihydroergotoxine; Dyskinesia, Drug-Induced; Ginkgo biloba; Humans; Hypnosis; Plant Extracts; Randomized Controlled Trials as Topic; Relaxation Therapy; Tetrabenazine; Valine | 2018 |
Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.
Topics: Aged; Dementia; Dyskinesia, Drug-Induced; Humans; Parkinsonian Disorders; Risk Factors; Tardive Dyskinesia; Tetrabenazine; Valine | 2018 |
1 trial(s) available for valine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
[Relationship between tardive dyskinesia and the polymorphism of superoxide dismutase val9Ala and efficacy of Chaihu Taoren Capsules on it].
Topics: Adolescent; Adult; Capsules; Drugs, Chinese Herbal; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Phytotherapy; Polymorphism, Genetic; Superoxide Dismutase; Valine; Young Adult | 2007 |
7 other study(ies) available for valine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Drug Approval; Dyskinesia, Drug-Induced; Humans; Severity of Illness Index; Tetrabenazine; United States; United States Food and Drug Administration; Valine | 2015 |
Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
Topics: Adult; Alleles; Antipsychotic Agents; Asian People; Brain-Derived Neurotrophic Factor; Dyskinesia, Drug-Induced; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genotype; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Korea; Male; Methionine; Polymerase Chain Reaction; Polymorphism, Genetic; Schizophrenia; Valine | 2009 |
Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
Topics: Aged; Antiparasitic Agents; Catechol O-Methyltransferase; Cohort Studies; Dyskinesia, Drug-Induced; Dyskinesias; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Methionine; Middle Aged; Parkinson Disease; Polymorphism, Genetic; Proportional Hazards Models; Valine | 2012 |
[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Topics: Aged; Alleles; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Gene Frequency; Genetic Variation; Genotype; Glycine; Haplotypes; Humans; Male; Middle Aged; Mutation; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Schizophrenia; Superoxide Dismutase; Valine | 2003 |
Negative association between catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia.
Topics: Adult; Amino Acid Substitution; Antipsychotic Agents; Brain Chemistry; Catechol O-Methyltransferase; Cohort Studies; Disease Progression; DNA Mutational Analysis; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Schizophrenia; Valine | 2005 |
Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
Topics: Adult; Alanine; Alleles; Antipsychotic Agents; Chromosomes, Human, Pair 6; Dyskinesia, Drug-Induced; Female; Genotype; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Reference Values; Schizophrenia; Superoxide Dismutase; Valine | 2007 |
Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
Topics: Animals; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Oocytes; Parkinson Disease, Secondary; Rats; Receptors, N-Methyl-D-Aspartate; Valine; Xenopus laevis | 1999 |